Allergy in patients with lymphangioleiomyomatosis
Rattachement africain : pl, es. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Lymphangioleiomyomatosis (LAM) is a rare disease caused by proliferation of abnormal smooth muscle-like cells, which can result in polycystic lungs destruction, formation of renal angiomyolipomas, lymphadenopathy, cystic lymphangiomas, abdominal lymphangioleiomyomas, chylothorax, and chyloperitoneum. The disease affects mainly women in childbearing age and occurs in two forms: as a sporadic lymphangioleiomyomatosis (sLAM) or associated with tuberous sclerosis complex (TSC/LAM).Pulmonary symptoms of LAM are frequently masked by allergy or asthma. The aim of the study was to present the differences between patients with and without allergic symptoms. Material: The study group comprised of women 89 with sLAM, and 25 women and one man with TSC/LAM. The assessment was performed at the time of first presentation in our Department. Results: 31 patients with LAM (29 with sLAM and 2 with TSC/LAM; p=0.011) displayed allergy symptoms. There were no differences between groups in mean age, smoking habits, time of diagnosis delay, presence of: pneumothorax in anamnesis lymphangioma, renal angiomyolipoma, and chylothorax, and mean serum concentration of VEGF-D. LAM patients with allergy had more severe lung impairment than patients without allergy [mean FVC(l) 3.26 vs. 3.28; p=0.65, mean FEV1(1.95 vs. 2.47l; p=0.005, mean DL,CO (4.42 vs. 5.84 mL/min/mmHg; p=0.007]. Allergic patients were more frequently treated with sirolimus than those without (81% vs. 49%; p=0.002). Conclusions: LAM patients with allergy more frequently: suffered on sporadic LAM, had severe lung function impairment, and were treated with mTOR inhibitors than patients without allergy.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Allergy in patients with lymphangioleiomyomatosis
- Date Crossref
- 07/09/2020
- Éditeur
- European Respiratory Society
- Type
- proceedings-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Edward F. Szczepanik State School of Higher Professional Education in Suwalki pays non établi dans la noticeUniversité ou école supérieure
-
Medical University of Lodz Department of Pneumology and Allergy pays non établi dans la noticeUniversité ou école supérieure
-
Institut d'Investigació Biomédica de Bellvitge pays non établi dans la noticeStructure de recherche
-
Institut Català d'Oncologia pays non établi dans la noticeOrganisme public
-
National Tuberculosis and Lung Diseases Research Institute l pays non établi dans la noticeStructure de recherche
-
District Hospital pays non établi dans la noticeÉtablissement de santé
-
Catalan Institute of Oncology pays non établi dans la noticeStructure de recherche
Edward F. Szczepanik State School of Higher Professional Education in Suwalki, Department of Pneumology and Allergy — Medical University of Lodz et Institut d'Investigació Biomédica de Bellvitge, avec 4 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.